US FDA Advisory Committees: Flipping FDAAA Mandate On Its Head

 
• By Michael McCaughan

FDA’s use of advisory committees is at a historic low – as are the prospects of sponsors getting a positive outcome. Is it COVID? Or a more fundamental shift in how FDA uses its panels?

FDA advisory committee drought
FDA's Great Room has been a little desolate of late. • Source: Nielsen Hobbs; the Pink Sheet | Alamy images

More from US FDA Performance Tracker

More from Regulatory Trackers